GSK's Velzatinib obtains ODD in Japan for GIST treatment
GSK•GSK said its velzatinib obtained orphan drug designation in Japan for treatment of gastrointestinal stromal tumors (GIST).
1. Japan designation
GSK said its velzatinib obtained orphan drug designation (ODD) in Japan for GIST treatment.




